A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
About this study
This is a retrospective and prospective study planned to include NSCLC patients with Leptomeningeal metastasis (LM) and treated with antitumor therapy after 2018, from multiple centers such as the First Affiliated Hospital of Guangzhou Medical University, Guangdong Sanjiu Brain Hospital, etc., aiming to establish a database related to the treatment strategies of LM patients, and to evaluate the efficacy (eg. Overall Survival/Time to Failure) and safety of different treatment strategies of LM patients, etc., as well as the significance of concomitant testing in LM patients.
- Condition
- Meningeal Metastasis, Non-Small Cell Lung Cancer
- Tested
- Not applicable- observational study
- Sponsor
- Guangzhou Medical University
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Study condition: Meningeal Metastasis, Non-Small Cell Lung Cancer
- non-small cell lung cancer patients with Leptomeningeal metastases diagnosed after January 2018;
- Patients who underwent antitumor therapy after diagnosis of LM.
Exclusion 2
- Patients with small cell lung cancer components;
- complicated with tumors other than non-small cell lung cancer.
Where
2 sites, 2 recruiting
Guangdong Sanjiu Brain Hospital
Guangzhou, Guangdong, China
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Contact
-
hong hai Yang
13711244230 bjrf2009@yahoo.com
Potential match only. Final eligibility is determined by the study team.